NCT02015273View on ClinicalTrials.gov

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Growth Disorders
Interventions
DEVICE

easypod™

Saizen® (Somatropin) as per Summary of Product Characteristics administered by easypod™

Trial Locations (6)

Unknown

Anakku Clinic Pondok Pinang, Jakarta

KK Women's & Children's Hospital, Singapore

National University Hospital, Singapore

Kaohsiung Medical University Hospital, Kaohsiung City

Chung Shan Medical University Hospital, Taichung

Taipei Medical University Hospital, Taipei

All Listed Sponsors
collaborator

Merck Ltd., Taiwan

INDUSTRY

collaborator

PT Merck Tbk., Indonesia, an affiliate of Merck KGaA, Darmstadt, Germany

UNKNOWN

collaborator

Merck Pte. Ltd., Singapore

INDUSTRY

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT02015273 - To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore) | Biotech Hunter | Biotech Hunter